Equity Mates Investing Podcast cover image

The drug beating Ozempic, Pimp my Portfolio with Luke Laretive & Australia's most popular small caps

Equity Mates Investing Podcast

00:00

Oral pills and valuation differences

Hosts discuss oral GLP-1 tablets, upcoming launches, and contrast Eli Lilly and Novo Nordisk valuations.

Play episode from 09:50
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app